Atlas Trials

Xin-Hua Xu

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xin-Hua Xu

RecordFirmDate
A Prospective, Open-label, Single-center, Single-arm Phase II Clinical Study of Cadonilimab (AK104) Combined With Monotherapy Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer With Negative Driver Genes and Failed Immunotherapy (NCT06467500)Xin-Hua Xu2024-03-01
A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma (NCT05749042)Xin-Hua Xu2023-01-18
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution. (NCT06029829)Xin-Hua Xu2023-01-12
Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes (NCT05792995)Xin-Hua Xu2021-12-21
A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma (NCT04367909)Xin-Hua Xu2020-06-21
A Study of Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma (NCT04411706)Xin-Hua Xu2020-06-21
A Study of Sintilimab or Placebo in Combination With Chemotherapy as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer With Wild-type EGFR After Failure With Platinum-Containing Chemotherapy. (NCT03863483)Xin-Hua Xu2019-03-26
A Study of Sintilimab Compared With Docetaxel or Pemetrexed as Second-line Treatment for Patients With Stage IV Nonsquamous Non-small Cell Lung Cancer After Failure With Platinum-Containing Chemotherapy (NCT03830411)Xin-Hua Xu2019-03-13

Track Xin-Hua Xu automatically

Every clearance here is in the API, with alerts when new ones post.